<DOC>
	<DOCNO>NCT00146029</DOCNO>
	<brief_summary>The purpose examine original breast tumor material see much metabolizing enzyme ( CYP3A4 ) present tumor material . The researcher want see way associate patient respond docetaxel . They also want examine gene tumor responsible production CYP metabolizing enzyme , see normal polymorphism , change compare 'normal ' CYP metabolize enzyme .</brief_summary>
	<brief_title>Companion Pharmacogenetic Study UMCC 9900/9901</brief_title>
	<detailed_description />
	<criteria>Patients participate UMCC 9900/9901 Living patient must give write informed consent No tumor block tissue available</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2008</verification_date>
	<keyword>Patients participate UMCC 9900/9901 ( Phase II Studies Tailored-Dose Docetaxel Metastatic Breast Cancer )</keyword>
</DOC>